Webinar on demand
In che modo TARGIT-A può avere effetti positivi su rimborsi e linee guida?
27 maggio 2021
· 37 MIN VISIONE
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/andrea-mckee.jpg/_jcr_content/renditions/original.image_file.100.100.0,17,506,523.file/andrea-mckee.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/andrea-mckee.jpg/_jcr_content/renditions/original.image_file.360.360.0,17,506,523.file/andrea-mckee.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/andrea-mckee.jpg/_jcr_content/renditions/original.image_file.506.506.0,17,506,523.file/andrea-mckee.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/andrea-mckee.jpg/_jcr_content/renditions/original.image_file.506.506.0,17,506,523.file/andrea-mckee.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/andrea-mckee.jpg/_jcr_content/renditions/original.image_file.506.506.0,17,506,523.file/andrea-mckee.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/andrea-mckee.jpg/_jcr_content/renditions/original.image_file.506.506.0,17,506,523.file/andrea-mckee.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/andrea-mckee.jpg/_jcr_content/renditions/original.image_file.506.506.0,17,506,523.file/andrea-mckee.jpg"})
Autore
Andrea McKee, MD
Presidente del Dipartimento di Radioterapia oncologica del Lahey Hospital & Medical Center, Burlington, MA, Stati Uniti
Riepilogo
Andrea McKee parla di TARGIT-A e del potenziale impatto sui rimborsi e sulle linee guida per il trattamento del tumore al seno con radioterapia intraoperatoria (IORT)
Questo webinar clinico registrato inizia con una breve panoramica sulla situazione delle linee guida globali per l’irradiazione parziale accelerata del seno (APBI), fornendo approfondimenti sulle diverse linee guida come ASTRO, ASBrS o ESTRO. Successivamente Andrea McKee discute e confronta in modo approfondito lo studio TARGIT-A con lo studio NSABP B39. Infine, si concentra sulla situazione dei rimborsi per il cancro al seno negli Stati Uniti, presentando il progetto pilota di rimborso RO-APM per i trattamenti IORT.
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/628-how-can-targit-a-have-positive-effects-on-reimbursement---gu_preview.jpg/_jcr_content/renditions/original.image_file.100.56.11,6,1921,1080.file/628-how-can-targit-a-have-positive-effects-on-reimbursement---gu_preview.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/628-how-can-targit-a-have-positive-effects-on-reimbursement---gu_preview.jpg/_jcr_content/renditions/original.image_file.360.203.11,6,1921,1080.file/628-how-can-targit-a-have-positive-effects-on-reimbursement---gu_preview.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/628-how-can-targit-a-have-positive-effects-on-reimbursement---gu_preview.jpg/_jcr_content/renditions/original.image_file.768.432.11,6,1921,1080.file/628-how-can-targit-a-have-positive-effects-on-reimbursement---gu_preview.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/628-how-can-targit-a-have-positive-effects-on-reimbursement---gu_preview.jpg/_jcr_content/renditions/original.image_file.1024.576.11,6,1921,1080.file/628-how-can-targit-a-have-positive-effects-on-reimbursement---gu_preview.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/628-how-can-targit-a-have-positive-effects-on-reimbursement---gu_preview.jpg/_jcr_content/renditions/original.image_file.1280.720.11,6,1921,1080.file/628-how-can-targit-a-have-positive-effects-on-reimbursement---gu_preview.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/628-how-can-targit-a-have-positive-effects-on-reimbursement---gu_preview.jpg/_jcr_content/renditions/original.image_file.1440.810.11,6,1921,1080.file/628-how-can-targit-a-have-positive-effects-on-reimbursement---gu_preview.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/628-how-can-targit-a-have-positive-effects-on-reimbursement---gu_preview.jpg/_jcr_content/renditions/original.image_file.1910.1074.11,6,1921,1080.file/628-how-can-targit-a-have-positive-effects-on-reimbursement---gu_preview.jpg"})
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.100.56.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.360.203.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.768.432.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.1024.576.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.1280.720.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.1365.768.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.1365.768.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png"})
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.100.56.79,35,1331,739.file/627-sperk-targit-a-preview.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.360.203.79,35,1331,739.file/627-sperk-targit-a-preview.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.768.432.79,35,1331,739.file/627-sperk-targit-a-preview.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.1024.576.79,35,1331,739.file/627-sperk-targit-a-preview.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.1252.704.79,35,1331,739.file/627-sperk-targit-a-preview.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.1252.704.79,35,1331,739.file/627-sperk-targit-a-preview.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.1252.704.79,35,1331,739.file/627-sperk-targit-a-preview.png"})